Product
Debio 1562
1 clinical trial
2 indications
Indication
Diffuse Large B-Cell LymphomaIndication
B-cell Non-Hodgkin's LymphomaClinical trial
A Phase 2 Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Patients With Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma and Other Forms of Non-Hodgkin's LymphomaStatus: Completed, Estimated PCD: 2021-01-13